samedan logo
 
 
spacer
home > ict > autumn 2017 > expert knowledge
PUBLICATIONS
International Clinical Trials

Expert Knowledge

After the US and Europe, Japan is the most important
market for biopharmaceutical R&D companies. The
Japanese pharmaceutical industry is worth $81 billion
and the major global companies have well-established
marketing and R&D operations in the region. Demands
for effective pharma products in Japan are growing,
but the current government emphasis on reducing
rising healthcare expenditure in the face of a rapidly
ageing population has made the business environment
challenging for the industry.

Japan has a mature, developed pharma market that is very
sensitive with respect to research quality, as the medical
community is exclusive, hierarchical and conservative.
Only 34% of clinical research is conducted by non-Japanese
businesses. During the late 1990s, several global CROs
expanded their operations, setting up offices in Japan to
coordinate global multicentre clinical trials as a part of their
drug development support to multinational companies.
In doing so, they have adapted to the different clinical
research environment in Japan, which is more resource-
focused and, therefore, more expensive when compared to
clinical trials in other regions.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Mary Pan is Vice President of General Management and Business Development at ICON, Asia Pacific, where she is responsible for growing and enhancing ICONís presence in the region. She has over 17 years of global pharma and clinical development expertise, with a strong track record in Asia through roles at Becton Dickinson, ClinTec International, Johnson & Johnson and Pfizer. Mary holds bachelor degrees in economics and psychology and a Master of Business Administration from Brown University, US, and also has a law degree from the University of Edinburgh, UK.
spacer
Mary Pan
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Charles River Laboratories Announces Extended Relationship with The Michael J. Fox Foundation

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced an extension of its long-standing collaboration with The Michael J. Fox Foundation for Parkinsonís Research (MJFF), a leading organization working to support the diagnosis and treatment of Parkinsonís disease (PD). Since 2011, Charles River and MJFF have worked together to accelerate the discovery of therapies for PD. This latest extension includes grants from MJFF to support two projects:
More info >>

White Papers

The Importance of ADCC in Assessing Clinically Relevant Differences

Sartorius Stedim BioOutsource Ltd

Biosimilars have caused a revolution in the development of biologic drugs. The model for biosimilars is a combination of speed to market and low cost; these are fundamental to any biosimilar development project. The biosimilars pathway to approval is not always without difficulty, biosimilars are still relatively new, and as each new applicant is reviewed we are learning more and more about these molecules.
More info >>

 
Industry Events

HPLC 2018

29 July - 2 August 2018, Washington Marriott Wardman Park, Washington, DC, USA

Are you interested in mass spectrometry, chromatography, or electrophoresis? Are you solving complex analytical problems? Are you looking for a conference with strong scientific content, a robust program, presentations by world renowned experts, lectures by young scientists, courses offering great training opportunities, tutorials, panel discussions, vendor technical workshops, best poster competition, and a major exposition showcasing new product launches and innovative products? Mark your calendar to attend HPLC 2018 Washington, DC, the largest, most recognized international conference in the world devoted to advances in separation technologies!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement